Skip to main content
. 2021 Dec 29;2021:7055101. doi: 10.1155/2021/7055101

Table 1.

Baseline clinical characteristics of patients with spontaneous ICH in original cohort.

Clinical variables Total (n = 431) 3-month functional outcome 1-month mortality
Poor outcome (n = 327) Good outcome (n = 104) p value Death (n = 80) Survival (n = 351) p value
Age (year) 58.76 ± 12.92 59.09 ± 13.10 57.72 ± 12.34 0.557 58.88 ± 13.77 58.74 ± 12.74 0.981
Male 299 (69.4) 227 (69.4) 72 (69.2) 0.971 53 (66.3) 246 (70.1) 0.502
GCS 13 (8,15) 12 (7,14) 15 (14,15) <0.001 8 (6,11) 13 (10,15) <0.001
Admission SBP (mmHg) 167.72 ± 28.65 168.77 ± 29.76 164.42 ± 24.68 0.117 164.30 ± 31.79 168.50 ± 27.88 0.498
Admission DBP (mmHg) 98.10 ± 17.94 98.08 ± 18.46 98.16 ± 16.31 0.723 95.04 ± 19.41 98.79 ± 17.55 0.114
Onset to CT (hours) 6 (4,12) 6 (4,10) 7 (4,20) 0.020 5 (4,9) 6 (4,13) 0.262
History of hypertension 245 (56.8) 188 (57.5) 57 (54.8) 0.630 46 (57.5) 199 (56.7) 0.896
History of diabetes mellitus 31 (7.2) 28 (8.6) 3 (2.9) 0.051 3 (3.8) 28 (8.0) 0.187
Smoking 143 (33.2) 117 (35.8) 26 (25.0) 0.042 23 (28.7) 120 (34.2) 0.351
Previous stroke 22 (5.1) 19 (5.8) 3 (2.9) 0.238 2 (2.5) 20 (5.7) 0.373
Antiplatelet or anticoagulation 20 (4.6) 14 (4.3) 6 (5.8) 0.718 5 (6.3) 15 (4.3) 0.643
Hematoma volume (mL) 20.30 (7.81,35.78) 25.16 (9.06,40.42) 9.25 (2.64,21.70) <0.001 28.69 (10.72,49.69) 17.69 (7.05,32.94) <0.001
Hematoma location
 Supratentorial 358 (83.1) 284 (86.9) 74 (71.2) <0.001 66 (82.5) 292 (83.2) 0.882
 Infratentorial 73 (16.9) 43 (13.1) 30 (28.8) 14 (17.5) 59 (16.8)
Presence of IVH 170 (39.4) 147 (45.0) 23 (22.1) <0.001 57 (71.3) 113 (32.2) <0.001
Presence of HE 104 (24.1) 90 (27.5) 14 (13.5) 0.004 25 (31.3) 79 (22.5) 0.099
Treatment
 Surgical intervention 114 (26.5) 107 (32.7) 7 (6.7) <0.001 30 (37.5) 84 (23.9) 0.013
 Conservative treatment 317 (73.5) 220 (67.3) 97 (93.3) 50 (62.5) 267 (76.1)
PLT (10ˆ9/L) 151 (115,199) 151 (114,198) 150 (120,205) 0.824 143 (112,199) 151 (116,201) 0.374
PT (s) 11.4 (10.9,12.3) 11.4 (10.9,12.3) 11.6 (10.9,12.3) 0.482 11.8 (10.9,13.0) 11.4 (10.9,12.1) 0.075
APTT (s) 26.5 (23.7,29.7) 26.5 (23.7,29.4) 26.6 (23.8,30.3) 0.811 26.5 (23.5,30.1) 26.6 (23.8,29.5) 0.974
INR 0.99 (0.93-1.06) 0.98 (0.93,1.05) 1.00 (0.94,1.06) 0.153 1.00 (0.93,1.10) 0.98 (0.93,1.04) 0.066
NLR 8.18 (4.81,13.20) 8.77 (5.14,13.88) 6.44 (4.25,10.49) 0.001 12.53 (7.99,19.48) 7.35 (4.32,11.98) <0.001
Fibrinogen 2.76 (2.29,3.38) 2.92 (2.37,3.54) 2.44 (2.20,2.97) <0.001 3.34 (2.87,4.47) 2.65 (2.23,3.23) <0.001
F-NLR score
 0 164 (38.1) 102 (31.2) 62 (59.6) <0.001 7 (8.8) 157 (44.7) <0.001
 1 183 (42.5) 149 (45.6) 34 (32.7) 40 (50.0) 143 (40.7)
 2 84 (19.5) 76 (23.2) 8 (7.7) 33 (41.3) 51 (14.5)

Data are expressed as n (%), mean ± SD, or median (25th, 75th quartile). Abbreviation: ICH, intracerebral hemorrhage; SD, standard deviation; GCS, Glasgow Coma Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; IVH, intraventricular hemorrhage; HE, hematoma expansion; PLT, platelet; PT, prothrombin time; APTT, activated partial thromboplastin time; INR, international normalized ratio; F, fibrinogen; NLR, neutrophil to lymphocyte ratio.